Top Abstract Purchase Related
Home
>
Node
>
Subnode

Enhancement of amyloid induction by amyloid fibril fragments in hamster

Niewold, T.A.; Hol, P.R.; van Andel, A.C.; Lutz, E.T.; Gruys, E.

Laboratory Investigation; A Journal of Technical Methods and Pathology 56(5): 544-549

1987

ISSN/ISBN: 0023-6837
PMID: 3553738
Document Number: 303487
An extract (fibril amyloid-enhancing factor) prepared by sonication of a suspension of water-purified hamster AA-amyloid fibrils showed an amyloid-enhancing effect upon intraperitoneal injection into hamsters. The fibril amyloid-enhancing factor was identical to the original fibrils according to the results of infrared spectroscopy, gel filtration, gel electrophoresis, and Western blotting; although lyophilized samples of the extract did not show any green birefringence after staining with Congo red. From these results, it was concluded that fibril amyloid-enhancing factor represents small fragments of amyloid fibrils which enhance in vivo formation of amyloid fibrils.

Document emailed within 1 workday
Secure & encrypted payments

Skinner, M.; Benson, M.D.; Cohen, A.S. 1975: Amyloid fibril protein related to immunoglobulin lambda-chains Journal of Immunology 114(4): 1433-1435
Kimura, S.; Guyer, R.; Terry, W.D.; Glenner, G.G. 1972: Chemical evidence for lambda-type amyloid fibril proteins Journal of Immunology 109(4): 891-892
Matsumura, A.; Higuchi, K.; Shimizu, K.; Hosokawa, M.; Hashimoto, K.; Yasuhira, K.; Takeda, T. 1982: A novel amyloid fibril protein isolated from senescence-accelerated mice Laboratory Investigation; a Journal of Technical Methods and Pathology 47(3): 270-275
Nickerson, S.C. 1987: Amyloid fibril formation in the bovine mammary gland: an ultrastructural study Cytobios 51(205): 81-92
Korneeva, T.S.; Sura, V.V. 1970: The inhibiting effect of L-cysteine on the process of amyloid fibril formation in vitro and in vivo Biulleten' Eksperimental'noi Biologii i Meditsiny 69(4): 114-115
Tashima, T.; Kitamoto, T.; Tateishi, J. 1986: Histochemical classification of systemic amyloid fibril proteins. Alkaline guanidine method Archives of Pathology and Laboratory Medicine 110(10): 885-888
Naiki, H.; Nakakuki, K. 1996: First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro Laboratory Investigation; a Journal of Technical Methods and Pathology 74(2): 374-383
Snel, F.W.; Niewold, T.A.; Baltz, M.L.; Hol, P.R.; Van Ederen, A.M.; Pepys, M.B.; Gruys, E. 1989: Experimental amyloidosis in the hamster: correlation between hamster female protein levels and amyloid deposition Clinical and Experimental Immunology 76(2): 296-300
Ishihara, T.; Takahashi, M.; Koga, M.; Yokota, T.; Yamashita, Y.; Uchino, F. 1991: Amyloid fibril formation in the rough endoplasmic reticulum of plasma cells from a patient with localized A lambda amyloidosis Laboratory Investigation; A Journal of Technical Methods and Pathology 64(2): 265-271
Shah, P.L.; Gillmore, J.D.; Copley, S.J.; Collins, J.V.; Wells, A.U.; du Bois, R.M.; Hawkins, P.N.; Nicholson, A.G. 2002: The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 19(2): 134-142
Sinha, N.; Tsai, C.J.; Nussinov, R. 2001: A proposed structural model for amyloid fibril elongation: domain swapping forms an interdigitating beta-structure polymer Protein Engineering 14(2): 93-103
Sipe, J.D.; Ignaczak, T.F.; Pollock, P.S.; Glenner, G.G. 1976: Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay Journal of Immunology 116(4): 1151-1156
Akiyama, T.; Seishima, M.; Nojiri, M.; Satoh, M.; Ichiki, Y.; Kitajima, Y. 1999: Partial amino acid sequence of an amyloid fibril protein from unusual cutaneous cystic lesions in myeloma-associated amyloidosis European Journal of Dermatology: Ejd 9(8): 624-628
Shapira, E.; Yogev, R.; Pras, M.; Russell, A. 1973: Specific antiserum to rheumatoid arthritis amyloid and its cross reactivity with various amyloid preparation Israel Journal of Medical Sciences 9(7): 868-874
Caspi, D.; Baltz, M.L.; Feinstein, A.; Munn, E.A.; Pepys, M.B. 1984: 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils Clinical and Experimental Immunology 57(3): 647-656
Baltz, M.L.; Rowe, I.F.; Caspi, D.; Turnell, W.G.; Pepys, M.B. 1986: Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? Clinical and Experimental Immunology 66(3): 701-708
Mazanec, K.; McClure, J.; Bartley, C.J. 1992: Amyloid in articular cartilage--a new type of amyloid? Ceskoslovenska Patologie 28(3): 136-141
Farkas, Z.; Pákáski, M.; Penke, B.; Kása, P. 1997: Acetylcholine release induced in vitro by beta-amyloid and its fragments Neurobiology 5(1): 59-61
Luan, T.-z.; Qi, J.-p.; Wang, D.-s.; Chen, Y.-x. 2005: Expression of amyloid beta protein and amyloid precursor protein after focal brain ischemia in human Zhonghua Yi Xue Za Zhi 85(25): 1770-1772
Baltz, M.L.; Gomer, K.; Davies, A.J.; Evans, D.J.; Klaus, G.G.; Pepys, M.B. 1980: Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains Clinical and Experimental Immunology 39(2): 355-360